Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business
  • Functional Area Sort descending
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Functional Area Sort descending Erscheinungsdatum
Patient Engagement Lead İstanbul Kavacık Türkei Corporate Affairs CTS Communications & Public Affairs Sep 03, 2024
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Deutschland International Innovative Medicines Communications & Public Affairs Jul 09, 2024
Public Affairs Manager Ankara Gimat Türkei International Innovative Medicines Communications & Public Affairs Sep 13, 2024
Communication & Patient Advocacy Manager (f/m/d) Vienna Österreich International CTS Communications & Public Affairs Sep 24, 2024
Manager, Post Production & Video Services Hyderabad (Office) Indien Corporate Affairs CTS Communications & Public Affairs Okt 04, 2024
Lead - Government Affairs Delhi (Office) Indien International Innovative Medicines Communications & Public Affairs Okt 15, 2024
Comms & Engagement Manager Amsterdam Niederlande Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Schweiz Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Associate Director, Political Affairs & Insights Washington, DC USA Corporate Affairs Corporate Communications & Public Affairs Okt 22, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Okt 22, 2024
Government Affairs Manager Moscow (City) Russische Foed. Corporate Affairs Innovative Medicines Communications & Public Affairs Okt 22, 2024
Associate Director, Corporate Event Marketing East Hanover (New Jersey) USA Corporate Affairs CTS Communications & Public Affairs Okt 22, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Okt 08, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Okt 08, 2024
Associate Director, Business Transformation & Engagement Barcelona Gran Vía Spanien Development Innovative Medicines Communications & Public Affairs Okt 23, 2024
Director of Commercial Policy Communications and Media Relations, Europe Basel (City) Schweiz Corporate Affairs CTS Communications & Public Affairs Okt 24, 2024
(Sr.) Public Affairs Manager Taipei Taiwan International Innovative Medicines Communications & Public Affairs Okt 20, 2024
Director of Global & Swiss Media & Editorial Basel (City) Schweiz Corporate CTS Communications & Public Affairs Okt 18, 2024
Manager, Corporate Communications Montreal Kanada Corporate Affairs CTS Communications & Public Affairs Okt 21, 2024
Chef, Communications corporatives Montreal Kanada Corporate Affairs CTS Communications & Public Affairs Okt 21, 2024
Sr. Spec. IT Solution Delivery INSURGENTES Mexiko Operations CTS Informationstechnologie Jul 15, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) Indien Operations CTS Informationstechnologie Okt 18, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Informationstechnologie Jul 22, 2024
(Senior) QA Operations Specialist Schaftenau Österreich Operations Innovative Medicines Quality Sep 26, 2024
QC Analyst II / Labortechniker (m/w/d), Schaftenau, Tirol Schaftenau Österreich Operations Innovative Medicines Quality Okt 07, 2024
AS&T Expert Schaftenau Österreich Operations Innovative Medicines Quality Okt 14, 2024
Research & Development Quality Specialist Barcelona Gran Vía Spanien Development Innovative Medicines Quality Okt 15, 2024
Compliance & Quality System Manager Ivrea Italien Operations Innovative Medicines Quality Okt 17, 2024
QC Analyst II. Basel (Land) Schweiz Operations Innovative Medicines Quality Sep 03, 2024
Senior QC Specialist Kundl Österreich Operations Innovative Medicines Quality Sep 09, 2024
QC Site Manager / Responsable CQ - pharmacien adjoint SCL - H/F Saint-Cloud Frankreich Operations Innovative Medicines Quality Sep 03, 2024
Associate Director Data Ops & Analytics, RDQ Hyderabad (Office) Indien Development Innovative Medicines Quality Sep 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Türkei Operations Innovative Medicines Quality Sep 03, 2024
Labortechniker / QC Analyst II (m/w/d), Tirol, Österreich Schaftenau Österreich Operations Innovative Medicines Quality Sep 03, 2024
QC Specialist Tech Resources & Compliance Durham USA Operations Innovative Medicines Quality Sep 03, 2024
QC Specialist I - Analytical Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
QC Specialist II - Analytical Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA USP) Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
Associate Manager - Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist İstanbul Kurtköy Türkei Operations Innovative Medicines Quality Sep 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA SF) Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 03, 2024
QC Analyst IV - Analytical Tuas South Avenue Singapur Operations Innovative Medicines Quality Jun 04, 2024
eCompliance Manager Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
Expert GMP Auditor Mumbai (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
AS&T Expert - Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist - Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.